Factor analysis of risk variables associated with low-grade inflammation

Atherosclerosis

Volumn 200, Issue 1, 2008, Pages 206-212

  Aronson, Doron ^a   Avizohar, Ophir ^a   Levy, Yishai ^a   Bartha, Peter ^a   Jacob, Giris ^a   Markiewicz, Walter ^a  

^a RAMBAM MEDICAL CENTER   (Israel)

Author keywords

C reactive protein; Factor analysis; Obesity; Physical fitness; Systemic inflammation

Indexed keywords

ALANINE AMINOTRANSFERASE; C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; EXERCISE TEST; FACTORIAL ANALYSIS; FEMALE; FITNESS; FORCED EXPIRATORY VOLUME; GLUCOSE BLOOD LEVEL; HUMAN; INFLAMMATION; LABORATORY TEST; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NEPHELOMETRY; OBESITY; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; TREADMILL EXERCISE; URIC ACID BLOOD LEVEL;

BIOLOGICAL MARKERS; BODY MASS INDEX; C-REACTIVE PROTEIN; EXERCISE TEST; FACTOR ANALYSIS, STATISTICAL; FEMALE; HUMANS; INFLAMMATION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RESPIRATORY FUNCTION TESTS; SMOKING;

EID: 49749138990     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2007.12.008     Document Type: Article

References (52)

1. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 340 (1999) 115-126
2. Pepys M.B., and Hirschfield G.M. C-reactive protein: a critical update. J Clin Invest 111 (2003) 1805-1812
3. Libby P., Ridker P.M., and Maseri A. Inflammation and atherosclerosis. Circulation 105 (2002) 1135-1143
4. Ridker P.M. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 103 (2001) 1813-1818
5. Ridker P.M. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 107 (2003) 363-369
6. Libby P., and Ridker P.M. Novel inflammatory markers of coronary risk: theory versus practice. Circulation 100 (1999) 1148-1150
7. Festa A., D'Agostino Jr. R., Howard G., Mykkanen L., Tracy R.P., and Haffner S.M. Chronic subclinical inflammation as part of the insulin resistance syndrome: the insulin resistance atherosclerosis study (IRAS). Circulation 102 (2000) 42-47
8. Aronson D., Bartha P., Zinder O., et al. Obesity is the major determinant of elevated C-reactive protein in subjects with the metabolic syndrome. Int J Obes Relat Metab Disord 28 (2004) 674-679
9. Ford E.S. Body mass index, diabetes, and C-reactive protein among U.S. adults. Diabetes Care 22 (1999) 1971-1977
10. Aronson D., Sella R., Sheikh-Ahmad M., et al. The association between cardiorespiratory fitness and C-reactive protein in subjects with the metabolic syndrome. J Am Coll Cardiol 44 (2004) 2003-2007
11. Aronson D., Sheikh-Ahmad M., Avizohar O., et al. C-reactive protein is inversely related to physical fitness in middle-aged subjects. Atherosclerosis 176 (2004) 173-179
12. Church T.S., Barlow C.E., Earnest C.P., Kampert J.B., Priest E.L., and Blair S.N. Associations between cardiorespiratory fitness and C-reactive protein in men. Arterioscler Thromb Vasc Biol 22 (2002) 1869-1876
13. Ruggiero C., Cherubini A., Ble A., et al. Uric acid and inflammatory markers. Eur Heart J 27 (2006) 1174-1181
14. Kerner A., Avizohar O., Sella R., et al. Association between elevated liver enzymes and C-reactive protein: possible hepatic contribution to systemic inflammation in the metabolic syndrome. Arterioscler Thromb Vasc Biol 25 (2005) 193-197
15. Yamada J., Tomiyama H., Yambe M., et al. Elevated serum levels of alanine aminotransferase and gamma glutamyltransferase are markers of inflammation and oxidative stress independent of the metabolic syndrome. Atherosclerosis 189 (2006) 198-205
16. Aronson D., Roterman I., Yigla M., et al. Inverse association between pulmonary function and C-reactive protein in apparently healthy subjects. Am J Respir Crit Care Med 174 (2006) 626-632
17. Lazarus R., Sparrow D., and Weiss S.T. Effects of obesity and fat distribution on ventilatory function: the normative aging study. Chest 111 (1997) 891-898
18. Jakes R.W., Day N.E., Patel B., et al. Physical inactivity is associated with lower forced expiratory volume in 1 second: European prospective investigation into cancer-Norfolk prospective population study. Am J Epidemiol 156 (2002) 139-147
19. Marchesini G., Bugianesi E., Forlani G., et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 37 (2003) 917-923
20. Chitturi S., Abeygunasekera S., Farrell G.C., et al. NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 35 (2002) 373-379
21. James O., and Day C. Non-alcoholic steatohepatitis: another disease of affluence. Lancet 353 (1999) 1634-1636
22. LaMonte M.J., Barlow C.E., Jurca R., Kampert J.B., Church T.S., and Blair S.N. Cardiorespiratory fitness is inversely associated with the incidence of metabolic syndrome: a prospective study of men and women. Circulation 112 (2005) 505-512
23. Cureton E.E., and D'Agostino R.B. Factor analysis, an applied approach (1983), L. Erlbaum Associates, Hillsdale, NJ
24. Stevens J. Applied multivariate statistics for the social sciences. 3rd ed. (1996), Lawrence Erlbaum Associates, Mahwah, NJ
25. Hankinson J.L., Odencrantz J.R., and Fedan K.B. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 159 (1999) 179-187
26. Bruce R.A., Kusumi F., and Hosmer D. Maximal oxygen intake and nomographic assessment of functional aerobic impairment in cardiovascular disease. Am Heart J 85 (1973) 546-562
27. Pearson T.A., Mensah G.A., Alexander R.W., et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the centers for disease control and prevention and the American heart association. Circulation 107 (2003) 499-511
28. Greenfield J.R., Samaras K., Jenkins A.B., et al. Obesity is an important determinant of baseline serum C-reactive protein concentration in monozygotic twins, independent of genetic influences. Circulation 109 (2004) 3022-3028
29. Wellen K.E., and Hotamisligil G.S. Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 112 (2003) 1785-1788
30. Mohamed-Ali V., Goodrick S., Rawesh A., et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab 82 (1997) 4196-4200
31. Ford E.S., Li C., Cook S., and Choi H.K. Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents. Circulation 115 (2007) 2526-2532
32. Thompson P.D., Buchner D., Pina I.L., et al. Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity). Circulation 107 (2003) 3109-3116
33. Mayer-Davis E.J., D'Agostino Jr. R., Karter A.J., et al. Intensity and amount of physical activity in relation to insulin sensitivity: the insulin resistance atherosclerosis study. JAMA 279 (1998) 669-674
34. Aronson D., Goldberg A., Roguin A., et al. Effect of obesity on the relationship between plasma C-reactive protein and coronary artery stenosis in patients with stable angina. Atherosclerosis 185 (2006) 137-142
35. Petersen A.M., and Pedersen B.K. The anti-inflammatory effect of exercise. J Appl Physiol 98 (2005) 1154-1162
36. Bruunsgaard H. Physical activity and modulation of systemic low-level inflammation. J Leukoc Biol 78 (2005) 819-835
37. Lakka T.A., Lakka H.M., Rankinen T., et al. Effect of exercise training on plasma levels of C-reactive protein in healthy adults: the HERITAGE family study. Eur Heart J 26 (2005) 2018-2025
38. Kasapis C., and Thompson P.D. The effects of physical activity on serum C-reactive protein and inflammatory markers: a systematic review. J Am Coll Cardiol 45 (2005) 1563-1569
39. Adamopoulos S., Parissis J., Kroupis C., et al. Physical training reduces peripheral markers of inflammation in patients with chronic heart failure. Eur Heart J 22 (2001) 791-797
40. Higgins M., Keller J.B., Wagenknecht L.E., et al. Pulmonary function and cardiovascular risk factor relationships in black and in white young men and women. The CARDIA study. Chest 99 (1991) 315-322
41. Pelkonen M., Notkola I.L., Lakka T., Tukiainen H.O., Kivinen P., and Nissinen A. Delaying decline in pulmonary function with physical activity: a 25-year follow-up. Am J Respir Crit Care Med 168 (2003) 494-499
42. Garcia-Aymerich J., Lange P., Benet M., Schnohr P., and Anto J.M. Regular physical activity modifies smoking-related lung function decline and reduces risk of chronic obstructive pulmonary disease: a population-based cohort study. Am J Respir Crit Care Med 175 (2007) 458-463
43. Frohlich M., Sund M., Lowel H., Imhof A., Hoffmeister A., and Koenig W. Independent association of various smoking characteristics with markers of systemic inflammation in men. Results from a representative sample of the general population (MONICA Augsburg Survey 1994/95). Eur Heart J 24 (2003) 1365-1372
44. Kuschner W.G., D'Alessandro A., Wong H., and Blanc P.D. Dose-dependent cigarette smoking-related inflammatory responses in healthy adults. Eur Respir J 9 (1996) 1989-1994
45. Carpagnano G.E., Kharitonov S.A., Foschino-Barbaro M.P., Resta O., Gramiccioni E., and Barnes P.J. Increased inflammatory markers in the exhaled breath condensate of cigarette smokers. Eur Respir J 21 (2003) 589-593
46. Riediker M., Cascio W.E., Griggs T.R., et al. Particulate matter exposure in cars is associated with cardiovascular effects in healthy young men. Am J Respir Crit Care Med 169 (2004) 934-940
47. Fredriksson M.I., Figueredo C.M., Gustafsson A., Bergstrom K.G., and Asman B.E. Effect of periodontitis and smoking on blood leukocytes and acute-phase proteins. J Periodontol 70 (1999) 1355-1360
48. Malfertheiner P., and Schutte K. Smoking-a trigger for chronic inflammation and cancer development in the pancreas. Am J Gastroenterol 101 (2006) 160-162
49. Mudway I.S., and Kelly F.J. An investigation of inhaled ozone dose and the magnitude of airway inflammation in healthy adults. Am J Respir Crit Care Med 169 (2004) 1089-1095
50. Wilkinson T.M., Donaldson G.C., Johnston S.L., Openshaw P.J., and Wedzicha J.A. Respiratory syncytial virus, airway inflammation, and FEV1 decline in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 173 (2006) 871-876
51. Munford R.S. Statins and the acute-phase response. N Engl J Med 344 (2001) 2016-2018
52. Brull D.J., Serrano N., Zito F., et al. Human CRP gene polymorphism influences CRP levels: implications for the prediction and pathogenesis of coronary heart disease. Arterioscler Thromb Vasc Biol 23 (2003) 2063-2069